[Pharmacological studies on butyl 6alpha-fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-oate (fluocortin butylester) (author's transl)].
D000287:Administration, Topical; D000818:Animals; D000893:Anti-Inflammatory Agents; D001169:Arthritis, Experimental / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D005260:Female; D005448:Fluocortolone / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D005938:Glucocorticoids; D007109:Immunity / Q000187:drug effects; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D011188:Potassium / Q000378:metabolism; D011244:Pregnadienediols / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011987:Receptors, Steroid / Q000187:drug effects; D012964:Sodium / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D005938:Glucocorticoids; D008112:Liver Glycogen; D011244:Pregnadienediols; D011987:Receptors, Steroid; D005448:Fluocortolone; D012964:Sodium; D011188:Potassium
Untersuchungen zur Pharmakologie von 6alpha-Fluor-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-säure-butylester (Fluocortin-butylester).